Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (3)

Search Parameters:
Keywords = DNA gyrase and DHFR inhibitors

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
31 pages, 7885 KiB  
Article
Sulfaguanidine Hybrid with Some New Pyridine-2-One Derivatives: Design, Synthesis, and Antimicrobial Activity against Multidrug-Resistant Bacteria as Dual DNA Gyrase and DHFR Inhibitors
by Ahmed Ragab, Sawsan A. Fouad, Ola A. Abu Ali, Entsar M. Ahmed, Abeer M. Ali, Ahmed A. Askar and Yousry A. Ammar
Antibiotics 2021, 10(2), 162; https://doi.org/10.3390/antibiotics10020162 - 5 Feb 2021
Cited by 57 | Viewed by 5917
Abstract
Herein, a series of novel hybrid sulfaguanidine moieties, bearing 2-cyanoacrylamide 2ad, pyridine-2-one 310, and 2-imino-2H-chromene-3-carboxamide 11, 12 derivatives, were synthesized, and their structure confirmed by spectral data and elemental analysis. All the synthesized compounds [...] Read more.
Herein, a series of novel hybrid sulfaguanidine moieties, bearing 2-cyanoacrylamide 2ad, pyridine-2-one 310, and 2-imino-2H-chromene-3-carboxamide 11, 12 derivatives, were synthesized, and their structure confirmed by spectral data and elemental analysis. All the synthesized compounds showed moderate to good antimicrobial activity against eight pathogens. The most promising six derivatives, 2a, 2b, 2d, 3a, 8, and 11, revealed to be best in inhibiting bacterial and fungal growth, thus showing bactericidal and fungicidal activity. These derivatives exhibited moderate to potent inhibition against DNA gyrase and DHFR enzymes, with three derivatives 2d, 3a, and 2a demonstrating inhibition of DNA gyrase, with IC50 values of 18.17–23.87 µM, and of DHFR, with IC50 values of 4.33–5.54 µM; their potency is near to that of the positive controls. Further, the six derivatives exhibited immunomodulatory potential and three derivatives, 2d, 8, and 11, were selected for further study and displayed an increase in spleen and thymus weight and enhanced the activation of CD4+ and CD8+ T lymphocytes. Finally, molecular docking and some AMED studies were performed. Full article
Show Figures

Figure 1

23 pages, 2481 KiB  
Article
Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity
by Ashraf S. Hassan, Ahmed A. Askar, Ahmed M. Naglah, Abdulrahman A. Almehizia and Ahmed Ragab
Molecules 2020, 25(11), 2593; https://doi.org/10.3390/molecules25112593 - 2 Jun 2020
Cited by 69 | Viewed by 5697
Abstract
A series of Bis-pyrazole Schiff bases (6ad and 7ad) and mono-pyrazole Schiff bases (8ad and 9ad) were designed and synthesized through the reaction of 5-aminopyrazoles 1ad with aldehydes [...] Read more.
A series of Bis-pyrazole Schiff bases (6ad and 7ad) and mono-pyrazole Schiff bases (8ad and 9ad) were designed and synthesized through the reaction of 5-aminopyrazoles 1ad with aldehydes 25 using mild reaction condition with a good yield percentage. The chemical structure of newly formed Schiff bases tethered pyrazole core was confirmed based on spectral and experimental data. All the newly formed pyrazole Schiff bases were evaluated against eight pathogens (Gram-positive, Gram-negative, and fungi). The result exhibited that, most of them have good and broad activities. Among those, only six Schiff bases (6b, 7b, 7c, 8a, 8d, and 9b) displayed MIC values (0.97–62.5 µg/mL) compared to Tetracycline (15.62–62.5 µg/mL) and Amphotericin B (15.62–31.25 µg/mL), MBC values (1.94–87.5 µg/mL) and selectivity to tumor cell than normal cells. Immunomodulatory activities showed that the promising Schiff bases increase the immunomodulator effect of defense cell and the Schiff base 8a is the highest one by (Intra. killing activity = 136.5 ± 0.3%) having a pyrazole moiety as well as amide function (O=C-NH2) and piperidinyl core. Furthermore, the most potent one exhibited broad activity depending on both MIC and MBC values. Moreover, to study the mechanism of these pyrazole Schiff bases, two active Schiff bases 8a and 9b from six derivatives were introduced to study the enzyme assay as dihydrofolate reductase (DHFR) on E. coli organism and DNA gyrase with two different organisms, S. aureus and B. subtilis, to determine the inhibitory activities with lower values in the case of DNA gyrase (8a and 9b) or nearly as DHFR compound 9b, while pyrazole 8a showed excellent inhibitory against all enzyme assay. The molecular docking study against dihydrofolate reductase and DNA gyrase were performed to study the binding between active site in the pocket with the two Schiff bases (8a and 9b) that exhibited good binding affinity with different bond types as H-bonding, aren-aren, and arene-cation interaction as well as study the physicochemical and pharmacokinetic properties of the two active Schiff bases 8a and 9b. Full article
(This article belongs to the Special Issue Nitrogen Heterocycles in Medicinal Chemistry)
Show Figures

Figure 1

13 pages, 381 KiB  
Article
Docking Studies in Target Proteins Involved in Antibacterial Action Mechanisms: Extending the Knowledge on Standard Antibiotics to Antimicrobial Mushroom Compounds
by Maria José Alves, Hugo J. C. Froufe, Ana F. T. Costa, Anabela F. Santos, Liliana G. Oliveira, Sara R. M. Osório, Rui M. V. Abreu, Manuela Pintado and Isabel C. F. R. Ferreira
Molecules 2014, 19(2), 1672-1684; https://doi.org/10.3390/molecules19021672 - 29 Jan 2014
Cited by 77 | Viewed by 12947
Abstract
In the present work, the knowledge on target proteins of standard antibiotics was extended to antimicrobial mushroom compounds. Docking studies were performed for 34 compounds in order to evaluate their affinity to bacterial proteins that are known targets for some antibiotics with different [...] Read more.
In the present work, the knowledge on target proteins of standard antibiotics was extended to antimicrobial mushroom compounds. Docking studies were performed for 34 compounds in order to evaluate their affinity to bacterial proteins that are known targets for some antibiotics with different mechanism of action: inhibitors of cell wall synthesis, inhibitors of protein synthesis, inhibitors of nucleic acids synthesis and antimetabolites. After validation of the molecular docking approach, virtual screening of all the compounds was performed against penicillin binding protein 1a (PBP1a), alanine racemase (Alr), d-alanyl-d-alanine synthetase (Ddl), isoleucyl-tRNA sinthetase (IARS), DNA gyrase subunit B, topoisomerase IV (TopoIV), dihydropteroate synthetase (DHPS) and dihydrofolate reductase (DHFR) using AutoDock4. Overall, it seems that for the selected mushroom compounds (namely, enokipodins, ganomycins and austrocortiluteins) the main mechanism of the action is the inhibition of cell wall synthesis, being Alr and Ddl probable protein targets. Full article
(This article belongs to the Collection Bioactive Compounds)
Show Figures

Graphical abstract

Back to TopTop